OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chemotherapy and cognition: comprehensive review on doxorubicin-induced chemobrain
Sara Emad El-Agamy, Amal Kamal Abdel‐Aziz, Ahmed Esmat, et al.
Cancer Chemotherapy and Pharmacology (2019) Vol. 84, Iss. 1, pp. 1-14
Closed Access | Times Cited: 78

Showing 51-75 of 78 citing articles:

Cancer‐related fatigue and treatment burden in surgically treated colorectal cancer patients – A cross‐sectional study
Anne Marie Lunde Husebø, Ingvild Dalen, Jon Arne Søreide, et al.
Journal of Clinical Nursing (2021) Vol. 31, Iss. 21-22, pp. 3089-3101
Open Access | Times Cited: 10

Betahistine Protects Doxorubicin-Induced Memory Deficits via Cholinergic and Anti-Inflammatory Pathways in Mouse Brain
Vasudevan Mani
International Journal of Pharmacology (2021) Vol. 17, Iss. 8, pp. 584-595
Closed Access | Times Cited: 10

Self-reported cognitive impairment in individuals with Primary Immunodeficiency Disease
Kerri Sowers, Christine A. Gayda-Chelder, Mary Lou Galantino
Brain Behavior & Immunity - Health (2020) Vol. 9, pp. 100170-100170
Open Access | Times Cited: 10

Attenuation of doxorubicin-induced oxidative damage in rat brain by regulating amino acid homeostasis with Astragali Radix
Xinyue Yu, Linling Guo, Xiaoying Deng, et al.
Amino Acids (2021) Vol. 53, Iss. 6, pp. 893-901
Closed Access | Times Cited: 9

A Short‐Lived but Highly Cytotoxic Vanadium(V) Complex as a Potential Drug Lead for Brain Cancer Treatment by Intratumoral Injections
Aviva Levina, Adriana Pires Vieira, Asanka Wijetunga, et al.
Angewandte Chemie (2020) Vol. 132, Iss. 37, pp. 15968-15972
Closed Access | Times Cited: 9

Dietary agents in mitigating chemotherapy-related cognitive impairment (chemobrain or chemofog): first review addressing the benefits, gaps, challenges and ways forward
Shamprasad Varija Raghu, Avinash K. Kudva, Suresh Rao, et al.
Food & Function (2021) Vol. 12, Iss. 22, pp. 11132-11153
Closed Access | Times Cited: 8

Functional Imaging of Chemobrain: Usefulness of Nuclear Medicine in the Fog Coming After Cancer
Agostino Chiaravalloti, Luca Filippi, Marco Pagani, et al.
Journal of Nuclear Medicine (2023) Vol. 64, Iss. 4, pp. 508-514
Open Access | Times Cited: 3

Targeting ryanodine receptor type 2 to mitigate chemotherapy-induced neurocognitive impairments in mice
Yang Liu, Steve Reiken, Haikel Dridi, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 715
Closed Access | Times Cited: 3

Protoflavones in melanoma therapy: Prooxidant and pro-senescence effect of protoapigenone and its synthetic alkyl derivative in A375 cells
Erika Csekes, Máté Vágvölgyi, Attila Hunyadi, et al.
Life Sciences (2020) Vol. 260, pp. 118419-118419
Closed Access | Times Cited: 8

Mapping the time dependent DNA fragmentation caused by doxorubicin loaded on PEGylated carbogenic nanodots using fluorescence lifetime imaging and superresolution microscopy
Chethana Rao, Shagun Sharma, Richa Garg, et al.
Biomaterials Science (2022) Vol. 10, Iss. 16, pp. 4525-4537
Closed Access | Times Cited: 5

Melatonin and metformin counteract cognitive dysfunction equally in male rats with doxorubicin-induced chemobrain
Titikorn Chunchai, Hiranya Pintana, Apiwan Arinno, et al.
NeuroToxicology (2022) Vol. 94, pp. 158-171
Closed Access | Times Cited: 5

Team Approach: Rehabilitation Strategies for Patients After Osteosarcoma Reconstructive Surgery
Tae W. Kim, Rohini J. Kumar, Kelly Gilrain, et al.
JBJS Reviews (2020) Vol. 8, Iss. 10, pp. e19.00225-e19.00225
Closed Access | Times Cited: 6

Identification of region-specific amino acid signatures for doxorubicin-induced chemo brain
Peijia Liu, Linling Guo, Xinyue Yu, et al.
Amino Acids (2023) Vol. 55, Iss. 3, pp. 325-336
Closed Access | Times Cited: 2

Doxorubicin induced aggregation of α-synuclein: Insights into the mechanism of drug induced Parkinsonism
Ankush Garg, Sharmistha Sinha
Colloids and Surfaces B Biointerfaces (2022) Vol. 212, pp. 112371-112371
Closed Access | Times Cited: 4

Episodic Memory and Recollection Network Disruptions Following Chemotherapy Treatment in Breast Cancer Survivors: A Review of Neuroimaging Findings
Meenakshie Bradley-Garcia, Gordon Winocur, Melanie J. Sekeres
Cancers (2022) Vol. 14, Iss. 19, pp. 4752-4752
Open Access | Times Cited: 4

Impact of “chemobrain” in childhood cancer survivors on social, academic, and daily living skills: a qualitative systematic review protocol
Ines Semendric, Danielle Pollock, Olivia J. Haller, et al.
JBI Evidence Synthesis (2021) Vol. 20, Iss. 1, pp. 222-228
Open Access | Times Cited: 4

Amelioration of Doxorubicin-Induced Cognitive Impairment by Quercetin in a Rat Model of Breast Cancer
Grandhi Venkata Ramalingayya, Jeena John, Karthik Gourishetti, et al.
Revista Brasileira de Farmacognosia (2022) Vol. 33, Iss. 1, pp. 153-163
Open Access | Times Cited: 3

Coenzyme Q10 ameliorates chemotherapy-induced cognitive impairment in mice: a preclinical study
Simranjit Kaur, Palak Ahuja, Lakshay Kapil, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access

Levetiracetam mitigates doxorubicin-induced Oxidative stress associated with Cognitive impairments and Neurodegeneration in experimental rats: In vivo and Molecular Modelling Studies
Vasudevan Mani, Syed Imam Rabbani, Minhajul Arfeen, et al.
Research Journal of Pharmacy and Technology (2024), pp. 3261-3267
Closed Access

Diagnostic and Treatment Approaches to Chemo Brain
Fatma Gül Helvacı Çelik, Meltem Puşuroğlu, Sefanur Köse, et al.
Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry (2024) Vol. 17, Iss. 2, pp. 301-322
Open Access

Brain metabolic changes in patients with disseminated malignant melanoma under immunotherapy
Marina Sizova, Valle Camacho, Frederic Sampedro, et al.
Melanoma Research (2022) Vol. 32, Iss. 5, pp. 334-342
Closed Access | Times Cited: 1

Doxorubicin-induced Toxicity Through the p38 MAPK Protein Kinase Pathway
Liyan Du
Highlights in Science Engineering and Technology (2022) Vol. 19, pp. 9-15
Open Access | Times Cited: 1

Reviews of Science for Science Librarians: Chemobrain
Tony Stankus
Science & Technology Libraries (2021) Vol. 40, Iss. 4, pp. 341-357
Closed Access | Times Cited: 1

Scroll to top